⚠ Evidence note: Nutrition evidence is dominated by observational data with heavy confounding; trial endpoints are mostly surrogates, not lifespan.
Glucose Control and CGM
Current understanding
Continuous glucose monitoring in non-diabetics — a biohacking staple with contested value.
Evidence log
- 2026-10-01 — TyG-ABSI and TyG-WWI as insulin-resistance body shape markers of mortality in middle-aged and older adults within the cardiovascular-kidney-metabolic framework: A multi-cohort observational study with external survival-model validation.: cross-connection with obesity-adiposity-aging: [human-observational] Composite triglyceride-glucose/body-shape indices link glucose-related metabolic markers with adiposity in mortality-risk assessment, but their limited incremental discrimination does not establish added clinical utility, validate CGM, or show that improving glucose or body-shape measures prolongs life. (novelty: 3)
- 2026-10-22 — Sustained Versus Minimal GLP-1 Receptor Agonist Exposure and Metabolic Outcomes in Older Adults Without Diabetes.: cross-connection with obesity-adiposity-aging: [human-observational] Sustained versus minimal GLP-1 receptor agonist exposure in older adults with obesity and without diabetes links adiposity changes to glycemic control and incident diabetes; HbA1c is a surrogate, diabetes incidence is a clinical outcome, and the study does not test CGM. (novelty: 3)
- 2026-11-04 — Longitudinal associations between the hallmarks of aging and body composition: a narrative review.: [human-observational] Narrative review of 50 longitudinal human studies identifies deregulated nutrient sensing, alongside chronic inflammation, as a principal evidence domain linking aging hallmarks to body-composition remodeling, but this broader nutrient-sensing evidence does not establish benefits from tighter glucose control or CGM use, including in people without diabetes. [human-observational] (novelty: 3)
- 2026-04-18 — Biobehavioral and Interpersonal Predictors of Cognitive Impairment in Older Adults With Type 2 Diabetes: A Systematic Review of Cohort Studies.: Systematic review of 43 cohort studies in older adults with T2D: higher HbA1c, glucose variability, and severe hypoglycemia episodes longitudinally predicted incident cognitive impairment and dementia — observational signal that glycemic instability (not just mean glucose) tracks with a hard neurocognitive endpoint, though confined to a diabetic population. [human-observational] (novelty: 3)
- 2026-07-27 — Global and regional projections of atherosclerotic cardiovascular-kidney-liver-metabolic disease burden to 2050: a forecasting analysis for the global burden of disease study 2023.: GBD-2023 forecast to 2050 projects T2DM among the metabolic antecedents roughly doubling and taking a larger share of CKLM burden — population-level projection framing dysglycemia as a growing driver of absolute disease burden, no direct bearing on CGM use. [human-observational] (novelty: 3)
- 2025-12-11 — Healthy diet and slower biological aging as protective factors against microvascular complications in type 2 diabetes.: cross-connection with healthy-dietary-patterns: Links diet quality to incident diabetic microvascular complications in T2DM, bridging dietary-pattern evidence with the glycemic-complication axis. (novelty: 3)
- 2026-06-08 — ACAT3 controls hepatic cholesterol metabolism and modulates systemic energy homeostasis of male mice.: Male-mouse study of hepatic ACAT3 knockout/overexpression reshapes bile-acid pools and systemic energy homeostasis, with hepatic ACAT3 expression falling in diabetic and aged mice — mechanistic candidate upstream of glycemic phenotypes, no human or CGM data. [animal-model] (novelty: 3)
- 2026-09-17 — Anticipatory metabolic regulation drives the distinct and improved metabolic state of caloric restriction compared to Fasting-Refeeding cycles.: cross-connection with intermittent-fasting: Fasting-refeeding cycles produced glucose intolerance in matched-intake rodents, a mechanistic caution for glycemic surrogate endpoints used to justify IF. (novelty: 3)
- 2026-08-13 — Essentials: How to Optimize Female Hormone Health for Vitality & Longevity | Dr. Sara Gottfried: Huberman Lab Essentials episode with Sara Gottfried frames perimenopausal insulin resistance and cardiometabolic risk as a rationale for tracking glucose alongside decade-specific hormone biomarkers in women — podcast synthesis of established guidance, no new trial data on CGM use in non-diabetic women. [expert-opinion] (novelty: 3)
- 2026-04-17 — Effects of chrononutrition on aging and lifespan.: cross-connection with time-restricted-eating: Review highlights circadian alignment of nutrient intake (carbohydrate timing, late-night eating) as a shared mechanism connecting TRE benefits to glucose regulation surrogates. (novelty: 3)
- 2026-07-13 — Sleep-related Alzheimer’s disease vulnerability in aging: A muscle-metabolic perspective.: Narrative review positions insulin resistance (alongside sarcopenia/sarcopenic obesity) as a modifier of sleep stability that may lower the threshold for sleep-driven Alzheimer’s amyloid/tau dyshomeostasis — hypothesis-generating, no new glycemic-variability or CGM outcome data. [mechanism-plausible] (novelty: 3)
- 2026-08-05 — Citrus Changshan Huyou extracts as natural GLP-1R agonists attenuate atherosclerosis via the GLP-1R/PKA/CREB pathway: a functional food perspective.: cross-connection with food-derived-glp1r-agonists: Both invoke GLP-1 pathway biology as a lever on metabolic aging endpoints, though the food-derived route has only rodent mechanism data so far. (novelty: 3)
- 2026-07-31 — Early life sugar rationing and ageing related diseases, biological ageing and mortality.: Tangential: UK Biobank sugar-rationing analysis links early-life sugar exposure (not adult glycemic variability) to later mortality and biological age — does not speak to CGM use in non-diabetic adults. [human-observational] (novelty: 4)
Open questions
Related
Contributing findings
Metabolic syndrome and Alzheimer's disease: Mechanistic links and precision prevention (Review).
13-nov-2026
novelty 2
per-area 2
strengthens
Longitudinal associations between the hallmarks of aging and body composition: a narrative review.
04-nov-2026
novelty 3
per-area 3
strengthens
Adropin signaling pathways in metabolic and non-metabolic disorders.
10-oct-2026
novelty 2
per-area 2
mentions
Aging Affects Pancreatic α‐Cell Function and Promotes Hyperglucagonemia: Implications in Age‐Associated Diabetes
06-oct-2026
novelty 3
per-area 2
strengthens
Sensory nutrition of sweet taste. Physiological, pathophysiological and pharmacological implications of T1R2/T1R3 signalling pathways on energy (glucose) and body weight homeostasis.
28-sep-2026
novelty 2
per-area 2
strengthens
Association between the triglyceride-glucose-body mass index and the risk of early vascular aging in young and middle-aged Chinese adults: a cross-sectional study.
25-sep-2026
novelty 2
per-area 2
strengthens
The Interplay of Metabolic Dysfunction, Neuroinflammation, and Mitochondrial Dysfunction in Balance Impairment: Insights from Type 2 Diabetes Mellitus and Alzheimer's Disease.
25-sep-2026
novelty 3
per-area 2
mentions
Sleep deprivation as a multi-system physiological stressor: A review of shared mechanisms and clinical implications.
23-sep-2026
novelty 2
per-area 2
strengthens
Cardiovascular health, as per life's essential 8, and unhealthy aging trajectories.
23-sep-2026
novelty 3
per-area 2
strengthens
Sex-based differences in the gut-metabolism axis in aging and Nrf2-deficient mice.
21-sep-2026
novelty 2
per-area 2
strengthens
Development of Smart Food /Nutraceutical Solutions Dedicated to Cardiometabolic Disorders in Ageing
14-sep-2026
novelty 2
per-area 2
mentions
Cluster-derived immunometabolic profiles: association with glycemic dysregulation in elderly postmenopausal women.
09-sep-2026
novelty 2
per-area 2
strengthens
Interactions between dietary intake and GLP-1 biology: implications for metabolic dysfunction and aging.
07-sep-2026
novelty 2
per-area 2
mentions
Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)
31-aug-2026
novelty 2
per-area 2
mentions
Effectiveness of a Multimodal Intervention on Function in Older Frail People With Diabetes in Latinamerican
28-aug-2026
novelty 3
per-area 2
mentions
#405 ‒ AMA #88: Metabolic liver health: how to assess risk, catch dysfunction early, and prevent or reverse liver disease
24-aug-2026
novelty 2
per-area 2
mentions
Chronic Disease and Disability in the United States: Trends, Inequities, and Imperatives for Policy Reform.
14-aug-2026
novelty 2
per-area 2
mentions
Essentials: How to Optimize Female Hormone Health for Vitality & Longevity | Dr. Sara Gottfried
13-aug-2026
novelty 3
per-area 3
strengthens
Body composition-defined sarcopenia phenotypes, diabetes complications, and CGM-derived glycemic profiles in frail older adults with diabetes: a cross-sectional study.
08-aug-2026
novelty 2
per-area 2
strengthens
Lactiplantibacillus plantarum AS21 Attenuates Sex-Biased Glucose Intolerance in Aging Mice via Gut Mucosal Microbiota-Derived Citrulline.
01-aug-2026
novelty 3
per-area 2
strengthens
Early life sugar rationing and ageing related diseases, biological ageing and mortality.
31-jul-2026
novelty 4
per-area 4
strengthens
The Impact of Diabetes Remission on Aging
30-jul-2026
novelty 2
per-area 2
mentions
Interaction between mental and cardiometabolic health in relation to telomere length among university staff in Australia.
29-jul-2026
novelty 2
per-area 2
strengthens
Global and regional projections of atherosclerotic cardiovascular-kidney-liver-metabolic disease burden to 2050: a forecasting analysis for the global burden of disease study 2023.
27-jul-2026
novelty 3
per-area 3
strengthens
Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus
21-jul-2026
novelty 2
per-area 2
mentions
Do Ketone Drinks Improve Immune, Metabolic and Cognitive Health in Older Adults
21-jul-2026
novelty 3
per-area 2
mentions
Community Dining, Walking, and Glucose in Older Adults
20-jul-2026
novelty 2
per-area 2
mentions
Sleep-related Alzheimer's disease vulnerability in aging: A muscle-metabolic perspective.
13-jul-2026
novelty 3
per-area 3
strengthens
Association of combined TyG-BMI and hs-CRP with incident cardiovascular disease in an aging Chinese population: A nationwide prospective cohort study.
02-jul-2026
novelty 2
per-area 2
strengthens
Effects of Exogenous Ketones on Cognitive Function in Older Adults With Prediabetes?
02-jul-2026
novelty 3
per-area 2
mentions
Heat and Exercise in Aging as Therapy (HEAT)
23-jun-2026
novelty 3
per-area 2
mentions
Glycine Supplementation Improves Cognitive Performance in Mexican Older Adults
15-jun-2026
novelty 3
per-area 2
mentions
ACAT3 controls hepatic cholesterol metabolism and modulates systemic energy homeostasis of male mice.
08-jun-2026
novelty 3
per-area 3
strengthens
Dendrobium officinale extends lifespan in yeast and Drosophila via context-dependent PI3K-AKT modulation.
30-apr-2026
novelty 2
per-area 2
mentions
Biobehavioral and Interpersonal Predictors of Cognitive Impairment in Older Adults With Type 2 Diabetes: A Systematic Review of Cohort Studies.
18-apr-2026
novelty 3
per-area 3
strengthens
The metabolic-inflammatory axis in aging: A multi-organ framework anchored in Sarcopenia - A review.
13-apr-2026
novelty 3
per-area 2
mentions
Sleep Improvement for Metabolic Health: A Feasibility Trial of a Digital Sleep Treatment in People With Insomnia and Non-Diabetic Hyperglycaemia.
15-feb-2026
novelty 2
per-area 1
mentions
Glycemic status-dependent proteomic signatures of biological aging for health risk prediction.
18-nov-2025
novelty 3
per-area 2
strengthens